Objective-Abdominal aortic aneurysms (AAAs) are associated with fragmentation of extracellular matrix during development of aortic dilation and rupture. Therefore, it is important to identify specific protease systems involved in extracellular matrix degradation during AAA formation. The present study determined the contribution of the urokinase system to AAA formation and rupture. Methods and Results-Angiotensin II (Ang II)-induced AAAs were associated with increased aortic abundance of both urokinase-type plasminogen activator receptor (uPAR) and urokinase-type plasminogen activator (uPA) proteins. However, this increased presence was unrelated to AAA formation because deficiencies of either uPAR or uPA had no effect on either the incidence or size of Ang II-induced AAAs in both normolipidemic mice and low-density lipoprotein receptorϪ/Ϫ mice fed a saturated fat-enriched diet. Although uPA deficiency did not affect development of AAAs, there was an effect of increasing mortality rate from AAA rupture in hypercholesterolemic mice. Bone marrow transplantation demonstrated that enhanced aneurysmal rupture was attributable to deficiency of uPA in leukocytes. uPA deficiency led to an increased propensity for impaired resolution of the thrombotic material within the aneurysmal tissue. Neither uPAR nor uPA deficiency had any effect on Ang II-induced atherosclerosis in low-density lipoprotein receptorϪ/Ϫ mice. Conclusion-The uPA-uPAR axis has no effect on the formation of Ang II-induced AAAs, but uPA deficiency promotes aneurysmal rupture. (Arterioscler Thromb Vasc Biol. 2011;31:2845-2852.)
tions that are associated with marked changes in the arterial tissue, including accumulation of several types of leukocytes and fragmentation of extracellular matrix (ECM). 1 Destruction of elastin and collagen is required for aortas to dilate and rupture. Several classes of proteases have been inferred in the degradation of matrix fibers, including matrix metalloproteinases (MMPs), cathepsins, and serine proteases. 2 Many of these proteases have been detected in aneurysmal tissue from humans and experimental animal models. [3] [4] [5] However, there is uncertainty regarding the functional roles of these proteases in the disease process and whether they differ in the initiation, progression, and rupture phases of aneurysmal development.
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Many laboratories have demonstrated that chronic subcutaneous angiotensin II (Ang II) infusion into mice promotes AAAs. [5] [6] [7] The prominent aortic lumen expansion that occurs during Ang II infusion is due to medial rupture within the first 10 days of infusion. 8 Days after the medial rupture, some mice succumb to AAA rupture. 8 Thrombi form at the site of medial rupture and provoke pronounced macrophage recruitment. This region becomes highly heterogeneous in gross appearance, with large variances of cellular and extracellular matrices within the aneurysmal region. Remodeling of the aneurysmal tissue occurs with thickening of aortic walls in regions that are distal and proximal to the pronounced lumen expansion. Therefore, like the human disease, development of Ang II-induced AAAs requires destruction of elastin and collagen to enable lumen expansion. 9 Furthermore, it is likely that proteases are required to enable the compositional changes that are characteristic of the progression and rupture of AAAs during Ang II infusion.
Urokinase-type plasminogen activator (uPA) is a serine protease that is initially secreted as an inactive single chain polypeptide. Although macrophages are a major source of uPA, uPA is also secreted by many other cell types present in AAAs, including endothelial cells, smooth muscle cells, and fibroblasts. uPA is cleaved by plasmin to form an active 2-chain molecule that is linked by 2 disulfide bridges. This active form promotes the cleavage of plasminogen to plasmin. This activation may be localized and enhanced by uPA interaction with a specific glycosylphosphotidylinositol-linked receptor, uPAR, although uPA can be activated independent of interaction with uPAR. 10 The generated plasmin may cleave ECM both directly and indirectly via MMP activation.
A single study has reported that uPA deficiency attenuates Ang II-induced AAAs in both apolipoprotein E (apoE)Ϫ/Ϫ mice and wild-type C57BL/6 mice. 11 Currently, no study has addressed either the role of uPAR or the source of uPA and uPAR involved in Ang II-induced AAAs. We found that Ang II infusion promoted an increased abundance of uPAR in aneurysmal tissue. Therefore, we hypothesized that deficiency of uPAR would attenuate Ang II-induced AAAs in low-density lipoprotein (LDL) receptorϪ/Ϫ mice. However, uPAR deficiency had no measurable effects on any facet of the aneurysmal process. Moreover, contrary to the previous publication, 11 uPA deficiency had no effect on the rate of formation of AAAs but enhanced death due to aneurysmal rupture. Deficiency of uPA in bone marrow-derived cells also enhanced mortality due to AAA rupture. Therefore, the uPA-uPAR axis had no discernable effect on formation of Ang II-induced AAAs, but uPA deficiency in leukocytes enhanced the fatal consequences of AAA formation through a uPAR-independent process.
Methods
For detailed Materials and Methods, please see the supplemental materials, available online at http://atvb.ahajournals.org.
Mice
LDL receptorϪ/Ϫ, apoEϪ/Ϫ, uPAϪ/Ϫ, uPARϪ/Ϫ, and C57BL/6 mice were purchased from the Jackson Laboratory. All study procedures were approved by the University of Kentucky Institutional Animal Care and Use Committee.
Mouse Genotyping
Genotypes of mice were confirmed by polymerase chain reaction of genomic DNA.
Diet and Ang II Infusion
Mice were fed a saturated fat-enriched diet and infused with saline or Ang II (1000 ng/kg per minute) as described previously. 6
Bone Marrow Transplantation
Bone marrow transplantation was performed as described previously. 12, 13 Blood Pressure Measurements Systolic blood pressure was measured using a tail-cuff system as described previously. 14
Cholesterol and uPA Concentration Measurements
Serum cholesterol concentrations and plasma uPA concentrations were measured as described in the supplemental materials.
Atherosclerosis and Aneurysm Analysis
Atherosclerosis and aneurysm analysis was quantified as described previously. 15, 16 
Gene Array
Gene array was performed according to manufacturer's protocol as described in the supplemental materials.
Zymography
Zymography of MMP-2, MMP-9, and uPA was performed as described previously. 5
Western Blot Analyses
Western blotting of uPAR, uPA, and ␤-actin was performed as described previously. 17
Histology and Immunostaining
Abdominal aortic sections were stained for elastin or collagen or immunostained for fibrinogen and macrophages as described previously. 18
Statistics
Detailed statistic analyses are described in the supplemental materials.
Results

Relative Aortic Abundance of uPAR and uPA in Hypercholesterolemic Mice
To examine the relative expression of uPAR and uPA, aortic tissues were extracted from LDL receptorϪ/Ϫ and apoEϪ/Ϫ mice before Ang II infusion. Interestingly, Western blots demonstrated that apoEϪ/Ϫ mice contained less uPAR protein in aortas as compared with LDL receptorϪ/Ϫ mice ( Figure 1A) . uPAR and apoE genes are closely linked on chromosome 7, which provides an impediment to the gener- ␤-Actin was used as loading control. Plasminogen zymography was performed to detect uPA activity. B, uPAR and uPA proteins were detected by Western blotting in protein extracts from aneurysmal tissues from LDL receptorϪ/Ϫ mice infused with either saline or angiotensin II (Ang II) for 14 days that were wildtype for both uPAR and uPA, uPARϪ/Ϫ, or uPAϪ/Ϫ. ␤-Actin was used as loading control. Plasminogen zymography was performed to detect uPA activity after 14 days of Ang II infusion. Quantification of protein abundances of uPAR (C) and uPA (D) in suprarenal aortic tissue excised from LDL receptorϪ/Ϫ mice infused with Ang II for 14 days that were wild-type for uPAR and uPA, uPARϪ/Ϫ, or uPAϪ/Ϫ. Images in A and B are representative of more than 4 independent experiments. ation of mice with compound deficiencies of the 2 genes. Therefore, we used mice in an LDL receptorϪ/Ϫ background to define the role of uPAR in Ang II-induced AAA formation in the present study. Accordingly, the effect of uPA in Ang II-induced AAAs was determined in the LDL receptorϪ/Ϫ mice. A previous publication has described the role of uPA in apoEϪ/Ϫ mice rather than LDL receptorϪ/Ϫ mice used in this study. 11 We found that there was no difference in expression and activity of uPA between apoEϪ/Ϫ and LDL receptorϪ/Ϫ mice ( Figure 1A ).
Ang II Increased uPAR and uPA in Aneurysmal Tissue
To determine whether uPAR and uPA were increased in aneurysmal tissue of Ang II-infused LDL receptorϪ/Ϫ mice, aortic tissue was extracted after 14 days of infusion with either saline or Ang II. Western blots detected the presence of uPA and uPAR protein after 14 days of either saline or Ang II infusion ( Figure 1B) .
Genotypes of uPAR-and uPA-deficient mice were phenotypically confirmed using Western blotting of aortic extracts. In addition, uPA genotypes were confirmed by the absence of uPA in plasma using an ELISA (data not shown) and by zymography for uPA activity in aortic extracts ( Figure 1B) . Quantification of Western blots demonstrated that uPA deficiency did not affect aortic uPAR protein abundance ( Figure  1C ), whereas Ang II infusion equivalently increased uPAR abundance in both uPAϩ/ϩ and Ϫ/Ϫ mice. In contrast, the uPA protein in aortas was more abundant in uPARϩ/ϩ than in uPARϪ/Ϫ mice ( Figure 1D ). There was an increase of uPA in aortas extracted from mice infused with Ang II compared with those infused with saline in both uPARϩ/ϩ and uPARϪ/Ϫ mice. Consistent with the finding in aortic tissues, uPA protein in macrophages was more abundant in uPARϩ/ϩ mice than in uPARϪ/Ϫ mice (Supplemental Figure I) . In contrast to the increase in aortic tissues, uPA protein abundance was not changed in macrophages after Ang II infusion in uPARϪ/Ϫ mice.
uPAR Deficiency Had No Effect on Ang II-Induced AAAs
To determine whether uPAR had a functional role in AAA development, either saline or Ang II was infused for 28 days into age-matched male LDL receptorϪ/Ϫ mice that were either uPARϩ/ϩ or uPARϪ/Ϫ. uPAR deficiency imparted a modest decrease of serum cholesterol concentrations and had no effect on systolic blood pressure during Ang II infusion ( Supplemental Table II ).
uPAR deficiency had no effect on diameter of the suprarenal aorta in mice infused with either saline or Ang II (Figure 2A ). Also, there was no change in the incidence of Ang II-induced AAAs in uPARϩ/ϩ mice (50% [9 of 18]) versus uPARϪ/Ϫ mice (61% [11 of 18] ). The incidence of aortic rupture was 24% (5 of 21) in uPARϩ/ϩ and 11% (2 of 19) in uPARϪ/Ϫ mice ( Figure 2B ) and the percentage survival rate over time of infusions did not attain statistical significance during the 28 days of Ang II infusion ( Figure 2C ). In addition to AAA formation, we determined the role of uPAR in atherosclerosis and found that deficiency of uPAR had no effect on the area of aortic atherosclerotic lesions ( Figure 2D ).
uPA Deficiency Did Not Influence Ang II-induced AAA Formation But Increased AAA Rupture uPA deficiency had no effect on diet-induced increases in serum cholesterol concentration or Ang II-induced increases in systolic blood pressure in age-matched male LDL receptorϪ/Ϫ mice ( Supplemental Table III ).
uPA deficiency did not alter the diameters of suprarenal aortas of saline-infused mice. Of the mice that survived 28 days of Ang II infusion, there was no significant difference in diameters of suprarenal aortas between uPAϩ/ϩ and uPAϪ/Ϫ mice ( Figure 3A ). However, a significantly greater number of uPA-deficient mice (47% [7 of 15]) succumbed to AAA rupture compared with uPA wild-type mice (12% [2 of 17]) during 28 days of Ang II infusion (PϽ0.05; Figure 3B ). There was no significant difference between the groups of mice in the combined end point of aneurysm or death due to aneurysmal rupture in uPAϩ/ϩ (88% [15 of 17] ) and uPAϪ/Ϫ mice (93% [14 of 15] ). However, there was a significant difference in survival rates between uPAϩ/ϩ and uPAϪ/Ϫ mice during 28 days of Ang II infusion (PϽ0.05; Figure 3C ). In addition, uPA deficiency had no effect on areas of atherosclerotic lesions ( Figure 3D ). Our data from uPAdeficient mice that were deficient in LDL receptors contrast 
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markedly with a previous study reporting a protective effect of uPA deficiency against Ang II-induced AAAs in apoEϪ/Ϫ mice. 11 The previous study also studied Ang II-induced AAAs in normocholesterolemic C57BL/6 mice. 11 AAAs that form from Ang II-infusion in normocholesterolemic mice appear grossly similar to those formed in either apoEϪ/Ϫ or LDL receptorϪ/Ϫ mice, although with much lower incidence. uPA deficiency was shown previously to reduce Ang II-induced AAAs in normocholesterolemic mice. 11 Therefore, we infused Ang II into male C57BL/6 mice that were either uPAϩ/ϩ or uPAϪ/Ϫ. Ang II infusion generated an equivalent increase in systolic blood pressure in the 2 groups ( Supplemental Table IV ). Unlike what was found in the previous study, uPA deficiency had no significant effect on Ang II-induced increases of suprarenal diameter (Figure 4 ). There was also no significant difference in the incidence of Ang II-induced AAA formation in uPAϩ/ϩ mice (45% [5 of 11]) and uPAϪ/Ϫ mice (42% [5 of 12]) or death due to AAA rupture (uPAϩ/ϩϭ0 versus uPAϪ/Ϫϭ1 mouse).
uPA Deficiency in Bone Marrow-Derived Cells Increased AAA Rupture
Because uPA is highly expressed in macrophages, we performed a bone marrow transplantation procedure to ablate uPA expression in cells of this origin to determine their role in aneurysmal rupture. LDL receptorϪ/ϪϫuPAϪ/Ϫ recipient mice were irradiated and repopulated with bone marrowderived stem cells harvested from either uPAϩ/ϩ or uPAϪ/Ϫ mice that were deficient in LDL receptors.
The chimerism was confirmed by polymerase chain reaction of bone marrow-derived DNA at the termination of the study ( Figure 5A ). Plasma concentrations of uPA were undetectable in irradiated uPAϪ/Ϫ recipient mice, irrespective of the uPA donor genotype. Also, the uPA genotype of donor cells did not influence the blood leukocyte count, serum cholesterol concentrations, or systolic blood pressure ( Supplemental Table V ). Bone marrow transplantation led to a lower incidence of Ang II-induced AAAs compared with nonirradiated mice, as noted previously. 12 Rupture was not observed in mice repopulated with cells from uPAϩ/ϩ mice (0% [0 of 24]). However, there was a significant increase in death due to AAA rupture in mice repopulated with cells from uPAϪ/Ϫ mice (32% [7 of 22]; Pϭ0.009; Figure 5B ).
Compositional Analyses of Aortic Tissue
To define the cellular and molecular mechanisms of increased rupture of Ang II-induced AAAs in uPAϪ/Ϫ mice, first we examined the histological features of the aneurysm-prone region of the suprarenal aorta from wild-type, uPARϪ/Ϫ, and uPAϪ/Ϫ mice before Ang II infusion. There were no discernable differences in dimensions or compositions in serial sections of aortas before Ang II infusion (Supplemental Figure II) .
The enhanced aortic rupture in uPAϪ/Ϫ mice may relate to changes in proteolysis during the early phase of AAA formation that affect tissue stability or thrombus resolution. To determine whether there was any difference in AAA tissues that would provide insight into enhanced aortic rupture during Ang II infusion in uPAϪ/Ϫ mice, we acquired suprarenal aortas in the early stage of AAA development (7 days) . For some of the tissues, RNA was isolated and a gene array was performed to determine mRNA abundance for several genes related to ECM and cellular adhesion. However, we were unable to discern any overt differences in mRNA abundances of these genes in suprarenal aortic tissues from uPAϩ/ϩ versus uPAϪ/Ϫ mice ( Supplemental Table  VI ). The wide variances of mRNA abundance are likely linked to the heterogeneity of Ang II-induced AAA tissues. Furthermore, the necessity to analyze whole tissue compromises the ability to detect localized changes that are likely to underlie the mechanisms of rupture. Hence, we also performed immunostaining on suprarenal aortic tissues after 7 days of Ang II infusion. Because macrophage presence has been implicated in thrombi resolution, we immunostained for this cell type. We were unable to discern any overt differences in macrophages present in aneurysmal thrombi from tissues between uPAϩ/ϩ and uPAϪ/Ϫ mice. The predominance of thrombi at this early interval of Ang II infusion provided an impediment to serial sectioning of aneurysmal tissue that might have negated quantitative assessment of macrophages as we reported recently. 19 Because we were unable to discern any differences in the early phase of AAA development, we also determined whether there were any morphological differences of AAAs between uPAϩ/ϩ or uPAϪ/Ϫ mice after 28 days of Ang II infusion. We examined the elastin fragmentation and medial rupture occurring in LDL receptorϪ/Ϫ mice that were wild-type, uPAϪ/Ϫ, or uPARϪ/Ϫ genotypes (indicated by arrows), which resulted in marked luminal dilation ( Figure  6A, 6E, 6I, and 6M ). This area included thrombi surrounded by ECM with a predominant collagen content that was similar among all groups ( Figure 6B, 6F, 6J, and 6N ). There was strong immunostaining for fibrin/fibrinogen in all AAAs. Counterstaining with hematoxylin demonstrated infiltration of cells into thrombi of wild-type and uPARϪ/Ϫ mice ( Figure 6C, D, G, H) . In contrast, thrombi in AAAs of uPAϪ/Ϫ mice were acellular, with minimal nuclei staining ( Figure 6K, 6L, 6O, and 6P ). Despite these compositional changes, neither uPA nor uPAR deficiency led to significant changes in latent or active forms of both MMP-2 and MMP-9 in aneurysmal tissue (Supplemental Figure III) .
Discussion
Ang II-induced AAAs form rapidly and exhibit large luminal expansions because of transmural fragmentation of ECM. 8, 20 The mechanisms of the proteolytic events involved in the initiation and propagation of Ang II-induced AAAs are undefined. However, 1 candidate system has been the uPA-uPAR axis. Despite the hypothetical involvement of this system in Ang II-induced AAAs, we found that deficiency of either uPA or uPAR had no discernable effect on development of the pathology, as defined by the incidence of the disease. In contrast, uPA deficiency in leukocytes led to increases in adverse consequences of aneurysm formation with increased mortality due to enhanced rupture of AAAs.
Both the initial dilation and the rupture phase of AAA formation involve degradation of ECM. Several proteases that degrade ECM have been detected in aneurysmal tissue promoted by Ang II infusion. These include uPA, MMP-2, MMP-9, and MMP-14. 5, 21, 22 uPA is the only one of these proteases to have been studied in deficient mice. 11 uPAR facilitates the localized activation of uPA to enable plasminogen to be cleaved to plasmin that may promote ECM degradation. The presence of uPAR facilitates macrophage infiltration into arterial walls of apoEϪ/Ϫ mice. 23 However, it is clear that uPAR is not an essential requirement for uPA activity. For example, unlike uPA deficiency, deletion of uPAR failed to influence healing in response to electric arterial injury. 10 In addition, uPAR deficiency does not affect the response of uPA to vascular injury, indicating that uPA has a uPAR-independent role on vascular remodeling after arterial injury. 10 In the present study, we demonstrated a lack of effect of uPAR deficiency on Ang II-induced AAAs in LDL receptorϪ/Ϫ mice.
Given the failure of uPAR deficiency to influence development of Ang II-induced AAAs in LDL receptorϪ/Ϫ mice, we assessed the effects of uPA deficiency that have been reported previously. 11 The present study failed to demonstrate a significant difference of uPA deficiency on AAA development in LDL receptorϪ/Ϫ mice that were strain-, gender-, and age-matched with wild-type mice. Additionally, we verified the presence or absence of uPA protein to confirm the genotype of the mice. We also confirmed the previous observation that uPA increased in Ang II-induced aneurysmal tissue. 5 Our finding that uPA had no effect on development of Ang II-induced AAAs contrasts sharply with the previous publication of Deng et al. 11 In their study, uPA deficiency in apoEϪ/Ϫ mice led to a reduction of Ang II-induced AAA incidence from 90% (9 of 10) to 22% (2 of 9). One obvious difference is the contrast of apoE versus LDL receptor deficiency to induce hypercholesterolemia. Although there have not been many direct comparisons between the mechanisms of Ang II-induced AAA formation in the 2 strains, there is no obvious difference in the pathological Uchida et al uPA-uPAR Axis on Ang II-Induced AAAs characteristics of the aneurysmal tissue. 5, 6, 8, 24 Also, there are no overt differences of Ang II-induced AAAs between LDL receptorϪ/Ϫ and apoEϪ/Ϫ mice with respect to location of formation, incidence, rate of onset, rupture rate, size, and gender preference. 6, 12 Although apoE-uPA compound deficient mice were not available, we were able to repeat the study of Deng et al 11 using uPA-deficient mice in normolipidemic C57BL/6 background. Ang II infusion causes AAAs in normocholesterolemic male mice, albeit with a much lesser incidence than strain-matched hypercholesterolemic mice. 11, 25 Nevertheless, we failed to detect any significant reduction in the incidence and size of AAAs in uPAϪ/Ϫ mice. Therefore, the discrepancy in findings between our studies and those of Deng et al 11 cannot be explained on the basis of differences in the hyperlipidemic background.
Proteases mediating Ang II-induced dilation may differ from those that regulate development of aortic rupture. Consistent with this notion, uPA deficiency had no effect on either the incidence or maximal external diameter of Ang II-induced AAAs. However, uPA deficiency increased mortality due to rupture of AAAs. Although uPA can be synthesized by several cell types, 26 the bone marrow transplantation study demonstrated that deficiency of uPA in infiltrating leukocytes also promoted rupture. We have demonstrated previously that marked luminal dilation of Ang II-induced AAAs precedes aortic rupture in this region by up to several days. 8, 20 Therefore, the process of proteolytic destruction of medial ECM is distinct from events leading to aortic rupture. We have also previously demonstrated that transmural thrombi occur in the early stage of luminal dilation that coincides with development of aortic rupture. 8 Therefore, it is likely that increased aortic rupture rates are determined by alterations in thrombi characteristics. We attempted to characterize aneurysmal tissues after 7 days of Ang II infusion to provide insight into the increased rate of rupture. However, a combination of the difficulty in serially sectioning thrombotic material, and the heterogeneity of the aneurysmal tissue presented a challenge to determine thrombus characteristics by immunostaining. 19 We also performed gene array of AAA tissues in the early phase of Ang II infusion but were unable to distinguish differences in the selected ECM and adhesion molecule genes examined in aneurysmal tissue between uPAϩ/ϩ and uPAϪ/Ϫ mice. Because of this inherent difficulty, we determined characteristics of aneurysmal tissue after 28 days of Ang II infusion. Although these tissues were extracted from mice that survived the 28 days of Ang II infusion, there were marked differences in the nature of aneurysmal tissue that included increased deposition of fibrin/fibrinogen and decreased nuclei in the remodeled region in uPAϪ/Ϫ mice. These changes in aneurysmal tissue are consistent with changes that have been noted previously in uPA-deficient mice subjected to ferric chloride-induced carotid lesions in apoEϪ/Ϫ mice. 27 Future studies will address the nature of the transmural thrombus and the effect of uPA deficiency on its characteristics.
MMPs have been detected in Ang II-induced aneurysmal tissue, with consistent demonstrations of MMP-9 and MMP-2. Using zymography, MMP-9 is usually detected almost exclusively in the latent form, whereas MMP-2 is routinely detected in both latent and activated forms. 28 No studies have used genetic deficiencies of these MMPs to demonstrate a direct role in Ang II-induced AAA formation, although pharmacological studies using a broad MMP inhibitor, doxycycline, showed reduced severity of the aortic pathology. 29 To the contrary, mice with MMP resistance to collagen degradation have increased Ang II-induced AAAs. 22 Although the direct effects of MMPs on Ang II-induced AAAs are unclear, similar to previous studies, we demonstrated the presence of the latent form of MMP-9 and both latent and active forms of MMP-2 in extracts of Ang II-induced AAAs. However, the deficiency of uPA or uPAR did not change the presence and activation of these MMPs. This lack of effect on MMP abundance in uPA-and uPARdeficient mice is consistent with the lack of effect on AAA formation.
Although atherosclerosis was not a primary end point of the current studies, in addition to AAAs, Ang II infusion also augments lesion development in both apoEϪ/Ϫ and LDL receptorϪ/Ϫ mice. 6, 12, 30 We were unable to demonstrate any effect of uPAR on size of atherosclerotic lesions. There have been a few studies defining the role of uPA on atherosclerosis that have demonstrated no effect of uPA deficiency on atherosclerosis in apoEϪ/Ϫ and apoE3-Leiden mice fed diets enriched in saturated fat, cholesterol, and cholate. 31, 32 In agreement with data derived using these other models, deficiency of uPA also had no effect on Ang II-induced atherosclerosis in LDL receptorϪ/Ϫ mice. Conversely, several studies have reported that overexpression of uPA in macrophages accelerates atherosclerosis and promotes cardiac fibrosis and macrophage accumulation. [33] [34] [35] The present study provided evidence that lack of uPA was associated with less fibrosis in thrombi. Similar to uPAR deficiency, lack of uPA deficiency had no effect on atherosclerosis. Overall, this study failed to demonstrate any significant effects of deficiency of the uPA-uPAR axis on Ang II-augmented atherosclerotic lesions.
In conclusion, our study has failed to demonstrate an effect of the uPA-uPAR axis on development of Ang II-induced AAAs under either normo-or hypercholesterolemic conditions. Unexpectedly, uPA deficiency led to profoundly increased death due to AAA rupture. The potential mechanism of this increased rupture rate may be related to the inability of uPA-deficient mice to resolve the transmural thrombi that are formed in the early phase of Ang II-induced AAAs.
